Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZFP62 mRNA | CTD | PMID:22206623 | 1-nitropyrene | increases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of ZFP62 mRNA | CTD | PMID:19041380 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP62 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP62 mRNA | CTD | PMID:21570461 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP62 mRNA | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFP62 mRNA | CTD | PMID:28628672 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ZFP62 mRNA | CTD | PMID:30807115 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ZFP62 mRNA | CTD | PMID:19770486 | aristolochic acid A | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZFP62 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP62 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | decreases methylation | ISO | ZFP62 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZFP62 5' UTR and Benzo(a)pyrene results in decreased methylation of ZFP62 promoter | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ZFP62 mRNA | CTD | PMID:22228805 | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA | CTD | PMID:27858113 | bilirubin IXalpha | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Bilirubin results in decreased expression of ZFP53 mRNA | CTD | PMID:20196124 | bisphenol A | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFP62 mRNA | CTD | PMID:28628672 | bisphenol A | affects expression | ISO | Zfp62 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ZFP62 mRNA | CTD | PMID:30816183 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ZFP62 mRNA | CTD | PMID:24982889 | carbamazepine | affects expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ZFP62 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ZFP62 mRNA | CTD | PMID:32715474 and PMID:37019170 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP62 gene | CTD | PMID:20938992 | chrysene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA | CTD | PMID:27858113 | copper(II) sulfate | increases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ZFP62 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of ZFP62 mRNA | CTD | PMID:29279043 | dexamethasone | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFP62 mRNA | CTD | PMID:28628672 | dichloromethane | increases expression | EXP | | 6480464 | Methylene Chloride results in increased expression of ZFP62 mRNA | CTD | PMID:28392392 | doxorubicin | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ZFP62 mRNA | CTD | PMID:29803840 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of ZFP62 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of ZFP62 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ZFP62 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP62 gene | CTD | PMID:20938992 | gallic acid | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Gallic Acid results in decreased expression of ZFP62 mRNA | CTD | PMID:34408198 | hydralazine | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZFP62 mRNA | CTD | PMID:17183730 | hydrogen peroxide | affects expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of ZFP62 mRNA | CTD | PMID:20044591 | indometacin | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFP62 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP62 gene | CTD | PMID:20938992 | leflunomide | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of ZFP62 mRNA | CTD | PMID:28988120 | menadione | affects expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of ZFP62 mRNA | CTD | PMID:20044591 | methidathion | decreases expression | EXP | | 6480464 | methidathion results in decreased expression of ZFP62 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | increases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ZFP62 mRNA | CTD | PMID:23649840 | methylisothiazolinone | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in decreased expression of ZFP62 mRNA | CTD | PMID:31629900 | ozone | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZFP62 mRNA | CTD | PMID:35430440 | pentanal | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | pentanal results in decreased expression of ZFP62 mRNA | CTD | PMID:26079696 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of ZFP62 mRNA | CTD | PMID:23091169 | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of ZFP62 mRNA | CTD | PMID:23608068 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of ZFP62 protein | CTD | PMID:25505154 | resveratrol | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ZFP62 mRNA | CTD | PMID:23557933 | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of ZFP62 mRNA | CTD | PMID:30529165 | tetraphene | decreases expression | EXP | | 6480464 | benz(a)anthracene results in decreased expression of ZFP62 mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA | CTD | PMID:27858113 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of ZFP62 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of ZFP62 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ZFP62 mRNA | CTD | PMID:28818685 | valproic acid | multiple interactions | ISO | ZFP62 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZFP62 mRNA | CTD | PMID:17183730 | valproic acid | decreases expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZFP62 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | ZFP62 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZFP62 mRNA | CTD | PMID:25979313 | |